Life Science Webinars

  1. Reduce Product Variability, Control Temp Rates To Improve Cell Therapies 2/4/2020

    Reduced input variables and careful freeze/thaw cycles are critical in T cell processing. Here, experts examine how these factors influence and optimize mononuclear cell enrichment and cryopreservation.

  2. Principles Of Immunogenicity Assessment Using Biacore T200 SPR System 2/4/2020

    Usually, ligand binding technologies such as ELISA are used for early immune responses, whereas SPR technology is utilized for the characterization of antibody isotypes.

  3. Process Characterization: Ready For The FDA? (Webinar) 1/31/2020

    In this webinar, Greg Sears, Ph.D, Global Director, Process Characterization, Head of Manufacturing Science and Technology, Pharma Services, Biologics at Thermo Fisher Scientific, discusses process characterization basics, including information on what’s optional vs. what’s required.

  4. Low-Temperature Solutions For Bioprocess Applications 12/26/2019

    This webinar discusses the needs and changing requirements of standard equipment and processes to handle lower temperatures and explains the importance of having a complete, cold-resistant solution of bags, tubing, connectors, and shells for freeze/ship/thaw processes.

  5. Advanced Analytical Tools For Drug Product Development 12/23/2019

    Gain insight into analytical techniques that reveal answers during product development, with an emphasis on Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS).

  6. A Roadmap For Early Development To Commercial Manufacturing 12/23/2019

    Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.

  7. Strategies To Develop Lipid-Based Drug Delivery Systems And Oral Dosage Forms 12/20/2019

    Liquid-filled capsules (LFC) are the primary delivery platform for oral delivery of lipid formulations which includes both softgels and liquid-filled hard capsules. Liquid-in-bottle is another avenue for delivering lipid formulations. Proper deployment of these technologies can provide formulators with effective delivery platforms during early-phase development and commercial products. In this webinar, industry experts discuss strategies to develop lipid-based drug delivery systems (LBDDS) for oral delivery. The experts share the fundamental principles, advantages and disadvantages of different dose forms for LBDDS and considerations for selecting a suitable dosage form for early phase development programs through commercialization.

  8. The Next Generation ODT 12/20/2019

    Orally dissolving tablets (ODT) are designed to dissolve rapidly on contact with saliva, therefore eliminating the need to chew the tablet, swallow the intact tablet, or take the tablet with liquids. Zydis® ODT fast-dissolve formulation from Catalent is a unique, freeze-dried tablet that disperses instantly in the mouth in less than three seconds. View the webinar to get an overview of the Zydis ODT technology, including new ways to administer peptides and vaccines. The webinar also presents the highlights of the next generation ODT technology, Zydis Ultra which can provide a better solution in terms of improved taste masking, innovative functional coating and a wide range of applications from Rx to OTC.

  9. Single Use Technologies For BDS Freeze/Ship/Thaw 12/18/2019

    Mike Johnson, Johannes Kirchmair (SUS)  explains the importance of having a complete, cold-resistant solution of bags, tubing, connectors, and shells.

  10. Choosing The Right CDMO For Late Phase Clinical Trials 11/21/2019

    For many pharmaceutical companies that do not have their own facilities, choosing the right partner for late-phase clinical trials and commercial production is a critical aspect in the management of parenteral products. This webinar offers insight into the importance of looking for a partner with extensive experience in the parenteral arena, as products move through clinical phases and toward commercialization.